LncRNA POU6F2-AS2 contributes to malignant phenotypes and paclitaxel resistance by promoting SKP2 expression in stomach adenocarcinoma

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Rodríguez-de-Santiago E, Hernanz N, Marcos-Prieto HM, et al. A multicentric Spanish study on the characteristics and survival of gastric adenocarcinoma under the age of 60. Gastroenterol Hepatol. 2019;42(10):595–603.
   PubMed Web of Science ®Google Scholar
• Han J, Tu J, Tang C, et al. Clinicopathological characteristics and prognosis of cT1N0M1 gastric cancer: a population-based study. Dis Markers. 2019;2019:5902091.
   PubMed Web of Science ®Google Scholar
• Castelló A, Fernández de Larrea N, Martín V, et al.; On behalf of the MCC-Spain researchers, High adherence to the Western, prudent, and mediterranean dietary patterns and risk of gastric adenocarcinoma: MCC-Spain study. Gastric Cancer. 2018;21(3):372–382.
   PubMed Web of Science ®Google Scholar
• Chi Y, Wang D, Wang J, et al. Long non-coding RNA in the pathogenesis of cancers. Cells. 2019;8(9):1015.
   PubMed Web of Science ®Google Scholar
• Yang Z, Tang Y, Lu H, et al. Long non-coding RNA reprogramming (lncRNA-ROR) regulates cell apoptosis and autophagy in chondrocytes. J Cell Biochem. 2018;119(10):8432–8440. Nov
   PubMed Web of Science ®Google Scholar
• Kundu M, Basu J. The role of microRNAs and long non-coding RNAs in the regulation of the immune response to Mycobacterium tuberculosis infection. Front Immunol. 2021;12:687962.
   PubMedGoogle Scholar
• Bhat AA, Younes SN, Raza SS, et al. Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance. Mol Cancer. 2020;19(1):57.
   PubMed Web of Science ®Google Scholar
• Liu J, Sun X, Zhu H, et al. Long noncoding RNA POU6F2-AS2 is associated with oesophageal squamous cell carcinoma. J Biochem. 2016;160(4):195–204.
   PubMed Web of Science ®Google Scholar
• Xu G, Zhu H, Xu J, et al. Long non-coding RNA POU6F2-AS2 promotes cell proliferation and drug resistance in colon cancer by regulating miR-377/BRD4. J Cell Mol Med. 2020;24(7):4136–4149.
   PubMed Web of Science ®Google Scholar
• Hu J, Xu L, Shou T, et al. Systematic analysis identifies three-lncRNA signature as a potentially prognostic biomarker for lung squamous cell carcinoma using bioinformatics strategy. Transl Lung Cancer Res. 2019;8(5):614–635.
   PubMed Web of Science ®Google Scholar
• Liang Y, Zhang C, Ma MH, et al. Identification and prediction of novel non-coding and coding RNA-associated competing endogenous RNA networks in colorectal cancer. World J Gastroenterol. 2018;24(46):5259–5270. Dec 14
   PubMed Web of Science ®Google Scholar
• Skaar JR, Pagan JK, Pagano M. Mechanisms and function of substrate recruitment by F-box proteins. Nat Rev Mol Cell Biol. 2013;14(6):369–381.
   PubMed Web of Science ®Google Scholar
• Kitagawa M, Lee SH, McCormick F. Skp2 suppresses p53-dependent apoptosis by inhibiting p300. Mol Cell. 2008;29(2):217–231.
   PubMed Web of Science ®Google Scholar
• Lin HK, Wang G, Chen Z, et al. Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by akt/PKB. Nat Cell Biol. 2009;11(4):420–432. Apr
   PubMed Web of Science ®Google Scholar
• Sun L, Cai L, Yu Y, et al. Knockdown of S-phase kinase-associated protein-2 expression in MCF-7 inhibits cell growth and enhances the cytotoxic effects of epirubicin. Acta Biochim Biophys Sin (Shanghai). 2007;39(12):999–1007. Dec
   PubMed Web of Science ®Google Scholar
• Wei X, Li X, Yan W, et al. SKP2 promotes hepatocellular carcinoma progression through nuclear AMPK-SKP2-CARM1 signaling transcriptionally regulating nutrient-deprived autophagy induction. Cell Physiol Biochem. 2018;47(6):2484–2497.
   PubMedGoogle Scholar
• Jiang F, Caraway NP, Li R, et al. RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells. Oncogene. 2005;24(21):3409–3418.
   PubMed Web of Science ®Google Scholar
• Li C, Du L, Ren Y, et al. SKP2 promotes breast cancer tumorigenesis and radiation tolerance through PDCD4 ubiquitination. J Exp Clin Cancer Res. 2019;38(1):76.
   PubMedGoogle Scholar
• Wen Y, Wang K, Yang K. Inhibiting the role of Skp2 suppresses cell proliferation and tumorigenesis of human gastric cancer cells via the upregulation of p27kip1. Mol Med Rep. 2016;14(4):3917–3924.
   PubMed Web of Science ®Google Scholar
• Takahari D. Second-line chemotherapy for patients with advanced gastric cancer. Gastric Cancer. 2017;20(3):395–406.
   PubMed Web of Science ®Google Scholar
• Kadokura M, Iwasa S, Honma Y, et al. Weekly paclitaxel as second-line chemotherapy in japanese patients with advanced gastric cancer. Anticancer Res. 2013;33(10):4547–4552.
   PubMed Web of Science ®Google Scholar
• He W, Zhang D, Jiang J, et al. The relationships between the chemosensitivity of human gastric cancer to paclitaxel and the expressions of class III β-tubulin, MAPT, and survivin. Med Oncol. 2014;31(5):950.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ao X, Zhang JG, et al. Mechanisms of action and clinical implications of microRNAs in the drug resistance of gastric cancer. Front Oncol. 2021;11:768918.
   PubMed Web of Science ®Google Scholar
• Wei L, Sun J, Zhang N, et al. Noncoding RNAs in gastric cancer: implications for drug resistance. Mol Cancer. 2020;19(1):62.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ao X, Wang Y, et al. Long non-coding RNA in gastric cancer: mechanisms and clinical implications for drug resistance. Front Oncol. 2022;12:841411.
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(Database issue):D92–D97.
   PubMed Web of Science ®Google Scholar
• Lánczky A, Győrffy B. Web-based survival analysis tool tailored for medical research (KMplot): development and implementation. J Med Internet Res. 2021;23(7):e27633.
   PubMed Web of Science ®Google Scholar
• Iino K, Mitobe Y, Ikeda K, et al. RNA-binding protein NONO promotes breast cancer proliferation by post-transcriptional regulation of SKP2 and E2F8. Cancer Sci. 2020;111(1):148–159.
   PubMed Web of Science ®Google Scholar
• Ghafouri-Fard S, Taheri M. Long non-coding RNA signature in gastric cancer. Exp Mol Pathol. 2020;113:104365.
   PubMed Web of Science ®Google Scholar
• Wang H, Lu Y, Wang M, et al. Roles of E3 ubiquitin ligases in gastric cancer carcinogenesis and their effects on cisplatin resistance. J Mol Med (Berl). 2021;99(2):193–212.
   PubMed Web of Science ®Google Scholar
• Hao Z, Huang S. E3 ubiquitin ligase Skp2 as an attractive target in cancer therapy. Front Biosci (Landmark Ed). 2015;20(3):474–490.
   PubMedGoogle Scholar
• Geng Q, Liu J, Gong Z, et al. Phosphorylation by mTORC1 stablizes Skp2 and regulates its oncogenic function in gastric cancer. Mol Cancer. 2017;16(1):83.
   PubMedGoogle Scholar
• Lei Z, Xia X, He Q, et al. HSP70 promotes tumor progression by stabilizing Skp2 expression in gastric cancer cells. Mol Carcinog. 2021;60(12):826–839. Dec
   PubMed Web of Science ®Google Scholar
• Wei Z, Jiang X, Qiao H, et al. STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells. Cell Signal. 2013;25(4):931–938. Apr
   PubMed Web of Science ®Google Scholar
• Duan X, Bai J, Wei J, et al. MicroRNA-508-5p suppresses metastasis in human gastric cancer by targeting S-phase kinase‑associated protein 2. Mol Med Rep. 2017;16(2):2163–2171. Aug
   PubMed Web of Science ®Google Scholar
• Rodier G, Coulombe P, Tanguay PL, et al. Phosphorylation of Skp2 regulated by CDK2 and Cdc14B protects it from degradation by APC(Cdh1) in G1 phase. Embo J. 2008;27(4):679–691. Feb 20
   PubMed Web of Science ®Google Scholar
• Xu J, Zhou W, Yang F, et al. The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor. Nat Commun. 2017;8:14002.
   PubMed Web of Science ®Google Scholar
• Inuzuka H, Gao D, Finley LW, et al. Acetylation-dependent regulation of Skp2 function. Cell. 2012;150(1):179–193.
   PubMed Web of Science ®Google Scholar
• Guo Z, Wang X, Lin R, et al. Paclitaxel-based regimens as first-line treatment in advanced gastric cancer. J Chemother. 2015;27(2):94–98.
   PubMed Web of Science ®Google Scholar
• Feng P, Li L, Deng T, et al. NONO and tumorigenesis: more than splicing. J Cell Mol Med. 2020;24(8):4368–4376. Apr
   PubMed Web of Science ®Google Scholar
• Xie R, Chen X, Cheng L, et al. NONO inhibits lymphatic metastasis of bladder cancer via alternative splicing of SETMAR. Mol Ther. 2021;29(1):291–307.
   PubMed Web of Science ®Google Scholar
• Hu Z, Dong L, Li S, et al. Splicing regulator p54(nrb)/non-POU domain-containing octamer-binding protein enhances carcinogenesis through oncogenic isoform switch of MYC Box-Dependent interacting protein 1 in hepatocellular carcinoma. Hepatology. 2020;72(2):548–568.
   PubMed Web of Science ®Google Scholar
• Qin Z, Tong H, Li T, et al. SPHK1 contributes to cisplatin resistance in bladder cancer cells via the NONO/STAT3 axis. Int J Mol Med. 2021;48(5):204.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Qiao L, Dai Z, et al. LncNONO-as regulates AR expression by mediating NONO. Theriogenology. 2020;145:198–206.
   PubMed Web of Science ®Google Scholar
• Li D, Chen Y, Mei H, et al. Ets-1 promoter-associated noncoding RNA regulates the NONO/ERG/ets-1 axis to drive gastric cancer progression. Oncogene. 2018;37(35):4871–4886.
   PubMed Web of Science ®Google Scholar
• Xu W, He L, Li Y, et al. Silencing of lncRNA ZFAS1 inhibits malignancies by blocking wnt/β-catenin signaling in gastric cancer cells. Biosci Biotechnol Biochem. 2018;82(3):456–465.
   PubMed Web of Science ®Google Scholar
• YiRen H, YingCong Y, Sunwu Y, et al. Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer. Mol Cancer. 2017;16(1):174.
   PubMed Web of Science ®Google Scholar
• Ding J, Li D, Gong M, et al. Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer. OncoTargets Ther. 2014;7:1625–1630.
   PubMed Web of Science ®Google Scholar
• Wang H, Qin R, Guan A, et al. HOTAIR enhanced paclitaxel and doxorubicin resistance in gastric cancer cells partly through inhibiting miR-217 expression. J Cell Biochem. 2018;119(9):7226–7234.
   PubMed Web of Science ®Google Scholar
• Shang C, Sun L, Zhang J, et al. Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance. Oncotarget. 2017;8(9):15393–15398.
   PubMedGoogle Scholar
• Zhong Y, Lin H, Li Q, et al. CircRNA_100565 contributes to cisplatin resistance of NSCLC cells by regulating proliferation, apoptosis and autophagy via miR-337-3p/ADAM28 axis. Cancer Biomark. 2021;30(2):261–273.
   PubMed Web of Science ®Google Scholar
• Wu T, Gu X, Cui H. Emerging roles of SKP2 in cancer drug resistance. Cells. 2021;10(5):1147.
   PubMed Web of Science ®Google Scholar
• Yang Y, Lu Y, Wang L, et al. Skp2 is associated with paclitaxel resistance in prostate cancer cells. Oncol Rep. 2016;36(1):559–566. Jul
   PubMed Web of Science ®Google Scholar
• Fu L, Yin F, Li XR, et al. Generation and characterization of a paclitaxel-resistant human gastric carcinoma cell line. Anticancer Drugs. 2018;29(6):491–502.
   PubMed Web of Science ®Google Scholar